(1S,2R,6S)-2-butoxy-7-oxabicyclo[4.1.0]heptane

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 氧杂环己烷
• 英文名称: (1S,2R,6S)-2-butoxy-7-oxabicyclo[4.1.0]heptane
• 化学式: C₁₀H₁₈O₂
• 分子量: 170.25
• InChiKey: RIYIPDOELAHHGC-KXUCPTDWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  21.8
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• [EN] SULFONAMIDES DERIVED FROM TRICYCLYL-2-AMINOCYCLOALKANOLS AS ANTICANCER AGENTS<br/>[FR] SULFONAMIDES DÉRIVÉS DE TRICYCLYL-2-AMINOCYCLOALCANOLS EN TANT QU'AGENTS ANTICANCÉREUX
  申请人：ICAHN SCHOOL MED MOUNT SINAI

  公开号：WO2015138500A1

  公开（公告）日：2015-09-17

  A genus of arylsulfonamide derivatives of aminocycloalkanols is disclosed. The compounds are of the following genus (I):. The compounds induce FOXO1 transcription factor translocation to the nucleus by modulating PP2A and, as a consequence, exhibit anti-proliferative effects. They are useful in the treatment of a variety of disorders, including as a monotherapy in cancer treatment, or used in combination with other drugs to restore sensitivity to chemotherapy where resistance has developed.

  揭示了一类氨基环己醇基的芳基磺胺酰胺衍生物的属。这些化合物属于以下属(I)：这些化合物通过调节PP2A诱导FOXO1转录因子转位到细胞核，从而表现出抗增殖效果。它们在治疗各种疾病方面很有用，包括作为癌症治疗的单药疗法，或与其他药物结合以恢复对化疗的敏感性，特别是在发生耐药性时。
• [EN] CONSTRAINED TRICYCLIC SULFONAMIDES<br/>[FR] SULFAMIDES TRICYCLIQUES CONTRAINTS
  申请人：ICAHN SCHOOL MED MOUNT SINAI

  公开号：WO2015138496A1

  公开（公告）日：2015-09-17

  Tricyclic chemical modulators of protein phosphatase 2A are disclosed. The compounds are useful to treat cancer, age-onset proteotoxicity, stress-induced depression, inflammation, and acne. The compounds are of the following phenothiazine and dibenzoazepine compounds and similar genera:

  三环化学调节剂蛋白磷酸酶2A被披露。这些化合物可用于治疗癌症、年龄相关的蛋白质毒性、压力诱发的抑郁症、炎症和痤疮。这些化合物属于以下苯噻嗪和二苯并噻吩化合物及类似的类属：
• INHIBITORS OF INFLUENZA VIRUSES REPLICATION
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US20140142119A1

  公开（公告）日：2014-05-22

  Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.

  抑制生物样品或患者中流感病毒复制的方法，减少生物样品或患者中流感病毒的数量，以及治疗患者的流感的方法，包括向所述生物样品或患者投予有效量的由结构式（I）表示的化合物或其药学上可接受的盐，其中结构式（IA）的值如此处所述。所述化合物由结构式（IA）或其药学上可接受的盐表示，其中结构式（IA）的值如此处所述。药物组合物包括有效量的此类化合物或其药学上可接受的盐，以及药学上可接受的载体、佐剂或载体。
• SULFONAMIDES DERIVED FROM TRICYCLYL-2-AMINOCYCLOALKANOLS AS ANTICANCER AGENTS
  申请人：ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

  公开号：US20170015625A1

  公开（公告）日：2017-01-19

  A genus of arylsulfonamide derivatives of aminocycloalkanols is disclosed. The compounds are of the following genus: The compounds induce FOXO1 transcription factor translocation to the nucleus by modulating PP2A and, as a consequence, exhibit anti-proliferative effects. They are useful in the treatment of a variety of disorders, including as a monotherapy in cancer treatment, or used in combination with other drugs to restore sensitivity to chemotherapy where resistance has developed.
• CONSTRAINED TRICYCLIC SULFONAMIDES
  申请人：ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

  公开号：US20170015630A1

  公开（公告）日：2017-01-19

  Tricyclic chemical modulators of protein phosphatase 2A are disclosed. The compounds are useful to treat cancer, age-onset proteotoxicity, stress-induced depression, inflammation, and acne. The compounds are of the following phenothiazine and dibenzoazepine compounds and similar genera: